New oral pill tested for painful skin condition that antibiotics Can't fix
NCT ID NCT07228390
Summary
This study is testing whether a daily oral pill called ritlecitinib can safely reduce painful skin lumps in adults with moderate to severe hidradenitis suppurativa (HS), a chronic inflammatory skin disease. The 240 participants, whose HS did not improve with prior antibiotic treatment, will be randomly assigned to receive either the study drug or a placebo pill for 16 weeks. Researchers will compare the two groups to see if the drug is effective at reducing the number and severity of skin lesions and improving quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ClinOhio Research Services
NOT_YET_RECRUITINGColumbus, Ohio, 43213, United States
-
Dawes Fretzin Clinical Research Group, LLC
NOT_YET_RECRUITINGIndianapolis, Indiana, 46250, United States
-
Northridge Clinical Trials
NOT_YET_RECRUITINGNorthridge, California, 91325, United States
-
Revival Research Institute, LLC
RECRUITINGTroy, Michigan, 48084, United States
Conditions
Explore the condition pages connected to this study.